A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs-Reference-Cited by-同舟云学术

A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs

Published:2001-01 Issue:1 Volume:4 Page:16-31
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Doyle John J.,Casciano Julian,Arikian Steven,Tarride Jean-Eric,Gonzalez Marco A.,Casciano Roman

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference39 articles.

1. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases. Injuries and Risk Factors in 1990 and Projected to 2020;Murray,1996

2. The economic burden of depression in 1990;Greenberg;J Clin Psychiatry,1993

3. The costs of depression;Kind;Int Clin Psychopharmacol,1993

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value-based pricing of cognitive behavioral therapy for depression in primary care: an economic evaluation;BMC Health Services Research;2024-03-08

2. Sport Fan Motivation: A Comparison of Local, Nonlocal, and Distant National Basketball Association Fans in the United States and China;International Journal of Sport Communication;2023-03-01

3. Life-Threatening Cardiogenic Shock Related to Venlafaxine Poisoning—A Case Report with Metabolomic Approach;Metabolites;2023-02-27

4. Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder;Expert Review of Pharmacoeconomics & Outcomes Research;2020-11-23

5. The prospective, 24-week assessment of cost-efficacy of and compliance to antidepressant medications in a rural setting (PACECAR) study;Indian Journal of Psychiatry;2017